Supplementary Table S1 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Kevin Kwei
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
71Publications signalées
2553Citations signalées
0Affiliations récentes
Domaines associés
Chronic Lymphocytic Leukemia ResearchLymphoma Diagnosis and TreatmentChronic Myeloid Leukemia TreatmentsPI3K/AKT/mTOR signaling in cancerMultiple Myeloma Research and Treatments
Publications récentes
Supplementary table S2 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Table S3 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Methods S1 from B-cell Receptor Pathway Mutations Are Infrequent in Patients with Chronic Lymphocytic Leukemia on Continuous Ibrutinib Therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary table S2 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Data from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Table S3 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Table S1 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Methods S1 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Table S1 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary Table S3 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
Supplementary table S2 from B-cell receptor pathway mutations are infrequent in patients with chronic lymphocytic leukemia on continuous ibrutinib therapy
Jennifer A. Woyach, Paolo Ghia, John C. Byrd, Inhye E. Ahn et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.